Regulators are reportedly looking into the massive healthcare conglomerate’s potential anticompetitive effects, including the relationship between its health insurer UnitedHealthcare and physician network Optum.| Healthcare Dive
The new guidelines should give regulators sharper teeth in going after vertical and cross-market deals that have historically been difficult to challenge.| Healthcare Dive
The analysis comes as private equity investments in healthcare soar and regulators look to crack down on roll-up acquisitions.| Healthcare Dive